Neuberger Berman Group
VIVO

Neuberger Berman Group’s Meridian Bioscience Inc VIVO Stock Holding History

Neuberger Berman Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-140,146
Closed -$4.26M – 1920
2022
Q2 		$4.26M Buy
+140,146
New +$3.79M ﹤0.01% 933
2016
Q2 		– Sell
-788,597
Closed -$16.3M – 1593
2016
Q1 		$16.3M Sell
788,597
-588,457
-43% -$11.6M 0.02% 646
2015
Q4 		$28.3M Sell
1,377,054
-900,150
-40% -$17.3M 0.04% 499
2015
Q3 		$38.9M Sell
2,277,204
-331,176
-13% -$6.05M 0.05% 444
2015
Q2 		$48.6M Sell
2,608,380
-266,070
-9% -$4.93M 0.05% 427
2015
Q1 		$54.8M Sell
2,874,450
-115,533
-4% -$2.14M 0.06% 399
2014
Q4 		$49.2M Sell
2,989,983
-147,904
-5% -$2.54M 0.05% 427
2014
Q3 		$55.5M Sell
3,137,887
-562,567
-15% -$11.1M 0.06% 403
2014
Q2 		$76.4M Sell
3,700,454
-282,613
-7% -$5.81M 0.07% 357
2014
Q1 		$86.8M Sell
3,983,067
-36,272
-0.9% -$831K 0.09% 331
2013
Q4 		$107M Sell
4,019,339
-94,113
-2% -$2.31M 0.11% 284
2013
Q3 		$97.2M Sell
4,113,452
-93,747
-2% -$2.19M 0.11% 289
2013
Q2 		$90.5M Buy
+4,207,199
New +$90.7M 0.11% 279

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group's VIVO Position: Q3 2022 in Review

Neuberger Berman Group sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 140,146 shares — an estimated $4.26M sold.

Neuberger Berman Group first reported a position in VIVO in Q2 2013 and held it in 13 quarters. The position peaked at $107M in Q4 2013. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Neuberger Berman Group reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 140,146 Meridian Bioscience Inc shares in Q3 2022, an estimated $4.26M.
  • Neuberger Berman Group first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 13 quarters.
  • Neuberger Berman Group's Meridian Bioscience Inc position peaked at $107M in Q4 2013.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Neuberger Berman Group's 13F filing for Q3 2022, filed 15 Nov 2022.